Symphony Catheter
Payments companies reported to CMS as associated with Symphony Catheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Symphony Catheter, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Symphony Catheter
These are the largest totals companies reported as associated with Symphony Catheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Mahida | Cincinnati, OH | Cardiovascular Disease | $12,520.91 |
| Adam Raskin | Fairfield, OH | Cardiovascular Disease | $9,210.06 |
| Sripal Bangalore | New York, NY | Interventional Cardiology | $8,093.03 |
| Kalyan Veerina | Opelousas, LA | Interventional Cardiology | $6,497.00 |
| Terry Bowers | Troy, MI | Cardiovascular Disease | $3,671.28 |
| Robert Tomalty | Huntsville, AL | Vascular & Interventional Radiology | $3,505.39 |
| Rebekah Rharad | Tampa, FL | Nurse Practitioner | $3,091.81 |
| Jonathan Steinberger | Portland, OR | Vascular & Interventional Radiology | $2,842.53 |
| Derek Zipkin | Indianapolis, IN | Diagnostic Radiology | $2,834.94 |
| Hector Ferral | Evanston, IL | Vascular & Interventional Radiology | $2,507.22 |
Prescribed Symphony Catheter?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.